The dissemination of carbapenem-resistant Gram-negative bacilli (CRGNB) is a global
public health issue. CRGNB isolates are usually extensively drug-resistant or pandrug …

Introduction: The use of tigecycline (TG) for the treatment of Acinetobacter baumannii is
controversial. In this systematic review and meta-analysis, we aimed to better explore the …

Objectives To characterise the clinical features of Acinetobacter baumannii infections and
investigate the phylogenetic structure and transmission dynamics of A. baumannii in …

Background We investigated the associations between the different doses of tigecycline, its
efficacy and safety, and the role of tigecycline therapeutic drug monitoring for patients in the …

Background Tigecycline has in vitro bacteriostatic activity against a broad spectrum of
bacteria, including carbapenem-resistant Gram-negative bacteria (CR-GNB). However, the …

Carbapenem-resistant Acinetobacter baumannii (CRAB) produce resistance to various
classes of antibiotics and left limited options for treatment. This study was designed to …

Antimicrobial resistance (AMR) has emerged as a global public health crisis, compromising
the effectiveness of many life-saving antibiotics. The overuse and misuse of antimicrobial …